|
|||||
|
|
Pegylated liposomal doxorubicin plus cyclophosphamide followed by paclitaxel as primary chemotherapy in elderly or cardiotoxicity-prone patients with high-risk breast cancer: results of the phase II CAPRICE study |
|
| Authors: | Miguel J. Gil-Gil M. Bellet S. Morales B. Ojeda L. Manso C. Mesia E. Garcia-Martínez N. Martinez-Jáñez M. Melé A. Llombart S. Pernas P. Villagrasa C. Blasco J. Baselga |
| Affiliation: | 1. Department of Medical Oncology, Institut Català d’Oncologia-IDIBELL, L’Hospitalet de Llobregat, Avenida Gran Via 199-201, 08908, Barcelona, Spain 2. Department of Medical Oncology, Vall d’Hebron Institute of Oncology and Hospital, Universitari Vall d’Hebron, Barcelona, Spain 3. Department of Medical Oncology, Hospital Arnau de Vilanova, Lleida, Spain 4. Department of Medical Oncology, Hospital de Sant Pau, Barcelona, Spain 5. Department of Medical Oncology, Hospital 12 de Octubre, Madrid, Spain 6. Department of Medical Oncology, Hospital JM Morales Messeguer, Murcia, Spain 7. Department of Medical Oncology, Hospital Ramón y Cajal, Madrid, Spain 8. Department of Medical Oncology, Hospital Sant Joan, Reus, Spain 10. H. Arnau de Vilanova, Valencia, Spain 9. SOLTI Breast Cancer Research Group, Barcelona, Spain 11. Memorial Sloan Kettering Cancer Center, New York, USA |
| Abstract: | |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |